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A cell-type-specific membrane glycoprotein (SFA) of chicken (1) andhuman (2)
fibroblasts has been recently described from our laboratory . Malignantly
transformed fibroblasts lack SFA on their surface (3) . The same antigen is
present in serum and its molecular properties are similar to those of the cellular
antigen (4). The surface labeled protein present on normal but not on
transformed hamster fibroblasts (5, 6) seems to be the hamster counterpart of
SFA.' The serum concentration of SFA has been estimated to be in the order of
100 ug/ml and it was originally thought to represent a previously unknown serum
protein .
Here we show that SFA interacts with fibrin and appears in the serum
cryoglobulin fraction associated with cryofibrinogen . SFA has properties similar
to those of "cold insoluble globulin" (CIG) (7-9) and the two proteins seem to be
identical .
Materials and Methods
Reagents . Bovine fibrinogen (80% clottable) and fibrin powder were kindly provided by Dr .
Gunnar Myllyla (The Finnish Red Cross Blood Transfusion Center, Helsinki) . Human fibrinogen
(90% clottable) wasobtained from Kabi (Sweden) andwas further purified as describedby Finlayson
and Mosesson (10) . The purified preparation did notreveal any proteins other than fibrinogen when
tested in immunodiffusion at the concentration of 1 mg/ml against antinormal human serum
(Behringwerke, Marburg) .No SFA, a major contaminant of the original preparation, was detectable
in the purified fibrinogen .
Antisera .
￿
Production of antisera to SFA has been described (2) . Human fibroblasts (MRC-5)
cultured in 10% fetal calf serum were washed with buffer and treated with insoluble papain for 15
min. The material released was dialyzed, lyophilized, andused forimmunization of rabbits or sheep .
Such antisera were absorbed with calf serum and insolubilized papain and reacted with a single
component in fibroblast extracts and human serum or plasma in immunodiffusion .
Matrix-Bound Proteins .
￿
Fibrinogen waslinked to Sepharose beads (Pharmacia Fine Chemicals,
Inc., Sweden) according to Porath et al . (11) .
Purification of CIG.
￿
Outdated human plasma taken to citratewas used as starting material and
CIG was purified by cryoprecipitation followed by glycine precipitation and DEAE cellulose
chromatography as described by Mosesson and Umfleet (9) .
Affinity Chromatography on Sepharose-Conjugated PurifiedHumanFibrinogen .
￿
The Sepharose
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beads, 1.5 ml, were washed with 8M urea and suspended in phosphate-buffered saline (PBS) (5 ml)
containing 10-3 M-phenyl methyl sulphonyl fluoride (PMSF) as protease inhibitor . Humanserum (1
ml) wasaddedand the mixture wasshaken overnight at 0°C. The particles were washed with ice-cold
PBS (10 ml) three times and subsequently eluted by transferring thebeads to +37°C.Three eluates
with PBS (5 ml), each incubated for 5 min at +37°C, were collected . Theeluates were concentrated
and analyzed for protein by the method of Lowryet al . (12) and for SFAby radial immunodiffusion
(13) . Other human serum proteins were detected using immunodiffusion againstantinormal human
serum .
Interaction of SFA with Fibrin and Fibrinogen . The ambient temperature
during the formation of the blood coagulation clot and its removal by centrifuga-
tion greatly influenced the concentration of SFA in the resulting serum sample
(Table 1) . Serum prepared at +37°C contained slightly less SFA than the
corresponding plasma samples processed at +37°C, whereas serum obtained at
0°C had about 20% of this concentration . The original SFA concentration was
partly restored to samples clotted at 0°C if they were transferred to +37°C and
centrifuged to remove the clot at this temperature . No further removal of SFA
after removal of the clot could be achieved by centrifugation at low temperature .
The above results suggested that SFA was bound to the fibrin clot at low
temperature and that this binding could be prevented or reversed at +37°C .
Such binding was directly proven by subsequent experiments . SFA from serum
was bound to Sepharose-conjugated bovine or human fibrinogen (Fig . 1) and to
powdered human fibrin at 0°C and released at +37°C. No binding ofSFA could
be demonstrated to plain Sepharose particles or particles to which a human
serum albuminfraction was conjugated . Of the SFA present in the originalserum
sample 70-80% was bound to fibrinogen-Sepharose and about 5% could be
recovered showing a 10-fold purification of SFA relative to other proteins .
Co-purification of SFA and CIG .
￿
The purification procedure of CIG accord-
ing to Mosesson and Umfleet (9) showed concentration of SFA in the cryoprecipi-
tate fraction of human plasma (7- to 10-fold relative to other serum proteins) in
two experiments. The final product contained SFA with some fibrinogen and
small amounts of other serum proteins as analyzed by immunodiffusion . A
reaction of immunological identity was obtained with cellular SFAobtained with
papain digestion and with SFA from fibrinogen affinity chromatography .
SFA Concentration in Samples of Plasma and Serum Prepared in Two Experiments Using
Various Temperatures
Results
TABLE I
Sample
During clotting
Temperature
During removal of
clot or cells by
centrifugation
SFA
(% of
Exp . 1
concentration
plasma level)
Exp . 2
Plasma. - 37 1C 100 100
Serum 37°C 37°C 100 95
Serum 0°C +4°C 10 35
Serum 0°C 37°C - 95RUOSLAHTI AND VAHERI
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FIG . 1 .
￿
Immunodiffusion in agarose . Normal human serum A andD. Material bound to and
released from : B, Sepharose-conjugated fibrinogen ; C, unconjugated Sepharose; D, Sepharose-
conjugated albumin fraction ; andE, material obtained from acontrol tube without Sepharose.
Center well, anti-SFA .
Discussion
Co-purification of the fibroblast SF antigen present in serum and the cold
insoluble globulin CIG indicates that CIG and the serum SFA are the same
protein . This notion is reinforced by their similar S values . These are 12.3 S for
CIG (9) and 13.5 S for SFA (2) . Our recent results show that the polypeptide
composition ofhuman SFA (unpublished) closely resembles that of chicken SFA
(4) in being composed of two chains with mol wt close to 210,000 and a minor
component with a mol wt of about 150,000 . This is in agreement with the reported
composition of CIG of two chains with mol wt of about 250,000 (14) .
SFA is present on the surface of fibroblasts (1, 2) and glial cells (unpublished
observations) but not on several other types of cells . It is shed from the surface of
in vitro cultured fibroblasts and a parallel phenomenon occurring in vivo may
account for its presence in serum and plasma . It therefore seems that the protein
previously known as CIG originates from fibroblasts .
CIG is regularly found, along with cryofibrinogen, in the cryoprecipitate
fraction of human plasma, hence the name cold insoluble globulin (7) . This may
not be an appropriate designation for this protein, since our results show that
SFA/CIG is not insoluble at low temperatures as such . Centrifugation ofserum at
0°C failed to alter the SFA concentration of serum . It is likely that the
association of SFA with the plasma cryoprecipitate fraction is due to its affinity
to cryofibrinogen rather than its insolubility at low temperature . Our experi-
ments show that such an interaction does occur . SFA was bound to insolubilized
fibrinogen and fibrin at 0°C and could be released by elevating the temperature .
This phenomenon could be utilized to achieve a significant degree of purification
(10-fold) in a single exceedingly simple step .
The biological significance of the affinity of SFA to fibrin and fibrinogen is a
matter of speculation . Our unpublished data suggest that the cellular form of
SFA binds actin and we have evidence indicating that SFA is located in fibrillar
structures of the cell surface probably associated with microfilaments (15) . The
affinity of soluble SFA towards fibrinogen and fibrin could be demonstrated at
low temperature only . However, since the molecular mechanism of this interac-
tion is not known and results such as the requirement of high temperature for500
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dissociation of the complex suggest involvement of enzymatic events, it is
conceivable that interaction of cell surface SFA molecules with fibrin(ogen) may
have physiological significance .
Fibroblasts transformed with tumor viruses lack SFA (3, footnote 2) . Such cells
show increased fibrinolytic activity in vitro (16, 17). The characteristics of
transformed fibroblasts attributable to the increased fibrinolytic activity are
pronounced when the cells are plated on fibrin layer (18) . Whether interaction of
the fibroblast surface SFA with fibrin plays any role in these phenomena remains
to be seen .
A cell-type specific glycoprotein antigen (SFA) from fibroblast surface appears in
human plasma and serum . The amount ofSFA inserum was reduced ifthe blood
coagulation clot was removed at a low temperature . SFA could be bound to
Sepharose-conjugated fibrinogen and to fibrin powder at 0°C and was subse-
quently released when the temperature was elevated to +37°C . This procedure
resulted in a 10-fold enrichment of SFA relative to other serum proteins .
SFA was found to be concentrated in the cryoprecipitate fraction of human
plasma and was copurified with the cold insoluble globulin (CIG) with
procedures published for the purification of the latter component . SFÁ/CIG is
not insoluble at low temperatures as such and its appearance in the cryoprecipi-
tate fraction of plasma is likely to be due to its affinity to cryofibrinogen evident
from these experiments . The biological significance of the interaction of
fibroblast surface SFA molecules with fibrin(ogen) is not known.
We thank Mr . Yoshio Kawanowa and Mrs. Virpi Tiilikainen for technical assistance, Dr . Gunnar
Myllylä for providing the fibrin preparation and his advice . We are indebted to Prof. H. G. Schwick
and Dr . F . R. Seiler of Behringwerke for their suggestion that SFA andCIG mightbe thesame serum
protein .
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